Evercore ISI says three years of biotech underperformance may be ending. Gives its 5 favorite stocks
Evercore says biotech ‘winter is finally thawing’
We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
Moderna’s mRNA Dreams Meet Reality With First Post-Covid Shot
Deutsche Numis Reaffirms Their Hold Rating on BioNTech SE (BNTX)
BioNTech SE (NASDAQ:BNTX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
AstraZeneca Withdraws Covid-19 Vaccine, Citing Lack of Demand
Analysts’ Top Healthcare Picks: Vir Biotechnology (VIR), Rocket Pharmaceuticals (RCKT)
Buy Rating Affirmed for BioNTech Amid Strong Financials and Promising Oncology Pipeline
BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript
Strong Financials and Promising Oncology Pipeline Support Buy Rating for BioNTech SE
BioNTech reports net loss of €315.1m in Q1 2024
Buy Rating for BioNTech SE on Strong H2 Revenue Outlook and Promising Oncology Pipeline
Q1 2024 BioNTech SE Earnings Call
Q1 2024 BioNTech SE Earnings Call Transcript
BioNTech: Hold Rating Maintained Amidst Lower Q1 Earnings and Steady Revenue Outlook
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript
Jefferies Keeps Their Hold Rating on BioNTech SE (BNTX)
BioNTech Swings to First-Quarter Loss as Lower COVID-19 Commercial Sales Dents Topline
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.